Nextgen Biomed Ltd Share Price
Equities
NXGN
IL0010839301
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107 ILa | -5.98% | -1.11% | -15.88% |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.18M 10.35B 2.18B |
---|---|---|---|---|---|
Net income 2021 | -2M -761M -160M | Net income 2022 | -8M -3.05B -641M | EV / Sales 2021 | - |
Net cash position 2021 | 11.96M 4.55B 958M | Net cash position 2022 | 5.24M 1.99B 420M | EV / Sales 2022 | - |
P/E ratio 2021 |
-21.7
x | P/E ratio 2022 |
-3.17
x | Employees | 15 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 92.33% |
1 day | -5.98% | ||
1 week | -1.11% | ||
Current month | +0.09% | ||
1 month | +0.56% | ||
3 months | -17.44% | ||
6 months | -43.30% | ||
Current year | -15.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 19/11/22 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 16/01/23 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 07/08/00 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 11/06/22 |
Yaacov Amidror
CHM | Chairman | 75 | 06/01/21 |
Alon Pinkas
BRD | Director/Board Member | 62 | 16/11/22 |
Date | Price | Change | Volume |
---|---|---|---|
25/04/24 | 107 | -5.98% | 5,630 |
24/04/24 | 113.8 | +1.52% | 535 |
21/04/24 | 112.1 | +3.60% | 3,485 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 12:24 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-15.88% | 2.03M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+4.01% | 1.13B | |
+13.51% | 1.12B |
- Stock Market
- Equities
- NXGN Stock